4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-one

HCID 26955CAS 14901-07-6

基本情報

標準SMILES
CC(=O)C=CC1=C(C)CCCC1(C)C
InChIKey
PSQYTAPXSHCGMF-UHFFFAOYSA-N
分子式
C13H20O
平均分子量
192.3 g/mol
単同位体質量
192.15141526

概要

Beta-ionone is a colorless to light yellow liquid with an odor of cedar wood. In very dilute alcoholic solution the odor resembles odor of violets. Used in perfumery.

名称と識別子

優先名称
4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-one
IUPAC
4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one

名称と別名

14901-07-6RefChem:10697653-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-onebeta-JononeEC-Lonone4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-onebeta-IRISONE4-(2,6,6-Trimethyl-cyclohex-1-enyl)-but-3-en-2-oneIonone Impurity 113-Buten-2-one, 4-(2,2,6-trimethylcyclohexenyl)-DTXSID9025451
名称をさらに表示
(E)-1-(2,6,6-Trimethyl-1-cyclohexenyl)-1-butene-3-oneSCHEMBL23954CHEMBL3184146AKOS028109879I0077NS000757914-(2,6,6-trimethylcyclohexen-1-yl)-3-buten-2-one

データベース識別子

CAS
14901-07-6
PubChem CID
26955
DTXSID
DTXSID9025451
ChEMBL
CHEMBL3184146
EC Number
238-969-9

物性

構造計算による物性

XLogP
2.9
極性表面積
17.1 Ų
水素結合供与体数
0
水素結合受容体数
1
回転可能結合数
2
重原子数
14

実験および物理化学的性質

FragrancesFragrance Ingredient (beta-Ionone) -> IFRA transparency List
LogP · 2 件

log Kow = 4.0 at 25 °C

3.84

Odor · 2 件

Warm woody, dry, and fruity odor

Odor reminiscent of cedar wood; violet-like upon dilution

TasteWoody, berry, floral, green and fruity
Food AdditivesFLAVORING AGENT OR ADJUVANT -> FDA Substance added to food
Density · 2 件

0.9462 (NTP, 1992) - Less dense than water; will float

0.9461 at 20/4 °C

安全と法規制

GHS分類

GHS Classification · 6 件

This chemical does not meet GHS hazard criteria for 0.2% (4 of 2592) of reports.

Warning

H400 (17.2%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

P273, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2592 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Not Classified

危険有害性情報

Regulatory Information · 5 件

Chemical: 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-

Regulation (EC) No 1831/2003 (amended)

3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: 4-(2,6,6-trimethylcyclohex-1-ene-1-yl)-but-3-ene-2-one (EC: 238-969-9)

beta-Ionone: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Ionones: Human health tier II assessment
Fire PotentialCombustible liquid.
Health HazardsACUTE/CHRONIC HAZARDS: Toxic. May cause allergic reaction. (NTP, 1992)
FDA Requirements · 1 件

beta-Ionone is a food additive permitted for direct addition to food for human consumption as a synthetic flavoring substance and adjuvant in accordance with the following conditions: a) they are used in the minimum quantity required to produce their intended effect, and otherwise in accordance with all the principles of good manufacturing practice, and b) they consist of one or more of the following, used alone or in combination with flavoring substances and adjuvants generally recognized as safe in food, prior-sanctioned for such use, or regulated by an appropriate section in this part.

Reactive GroupKetones

安全と保護具

Fire FightingTo extinguish a fire involving this chemical you may use a dry chemical, carbon dioxide, foam or halon extinguisher; a water spray may also be used. (NTP, 1992)
First Aid · 1 件

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Fire Fighting Procedures · 3 件

Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

Advice for firefighters: Wear self-contained breathing apparatus for firefighting if necessary.

Extinguishing methods: Alcohol foam. Water or foam may cause frothing.

Storage ConditionsConditions for safe storage, including any incompatibilities: Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage.
Cleanup Methods · 1 件

ACCIDENTAL RELEASE MEASURES: Personal precautions, protective equipment and emergency procedures: Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.; Environmental precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.; Methods and materials for containment and cleaning up: Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed containers for disposal.

Nonfire Spill Response · 1 件

SMALL SPILLS AND LEAKAGE: If you spill this chemical, use absorbent paper to pick up all liquid spill material. Your contaminated clothing and absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with alcohol followed by washing with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

毒性情報

Interactions · 4 件

A possible role of metabolic activation by cytochrome P450 (P450) in thioacetamide-induced hepatotoxicity was investigated in male BALB/c mice. The mice were pretreated with the P450 inducer, beta-ionone, subcutaneously at 600 mg/kg, 72 and 48 hr prior to an intraperitoneal administration of either 100 or 200 mg/kg of thioacetamide. The elevated activities of serum alanine aminotransferase and serum aspartate aminotransferase by thioacetamide were greatly potentiated by the pretreatment with beta-ionone. Moreover, the potentiation of thioacetamide-induced hepatotoxicity was also observed in the histopathological examination of livers. The hepatic necrosis by thioacetamide was potentiated when mice were pretreated with beta-ionone. In liver microsomes, the activities of P450 2B-specific pentoxyresorufin O-depentylase and benzyloxyresorufin O-debenzylase were significantly induced by the treatment with beta-ionone. Beta-ionone also induced other P450-associated monooxygenases. Because the pretreatment with beta-ionone was not hepatotoxic at the dose inducing P450s. our present results suggest that beta-ionone may be a useful model inducer of P450 enzyme(s) in studying toxic mechanism of certain chemicals which require metabolic activation by P450s in mice.

Female ICR mice were treated with cocaine either alone or in combination with one of several cytochrome P450 (CYP) inducers, i.e. phenobarbital, beta-ionone, dexamethasone and beta-naphthoflavone. Cocaine-induced hepatotoxicity was first observed by pretreatment with phenobarbital, beta-ionone or dexamethasone in accordance with significant elevation of cocaine N-demethylation, the first step of cocaine bioactivation. The hepatic lesions occured in the periportal region (zone 1) by phenobarbital and beta-ionone and in the perivenular region (zone 3) by dexamethasone. The activities of the enzyme specific for CYP isozyme were determined to elucidate the effects of pretreatment with CYP inducers. Beta-naphthoflavone induced CYP1A and 2B but had no effects on hepatotoxicity by cocaine. On the other hand, beta-ionone enhanced hepatotoxicity without induction of CYP3A. Activities of cocaine N-demethylase correlated well with CYP2A (r=0.83) and CYP2B (r=0.81). Cocaine N-demethylation was inhibited particularly by addition of the CYP2A specific inhibitor, 8-methoxypsoralen. Moreover, pretreatment with 8-methoxypsoralen produced a marked inhibition of the hepatotoxicity induced by cocaine in phenobarbital-treated mice. These results suggest that cocaine-induced hepatotoxicity in female mice was mediated in part by CYP2A, participating in cocaine N-demethylation.

beta-Ionone demonstrates potent anticancer activity both in vitro and in vivo. We determined tumor incidence and the number of rats bearing tumors as well as cell proliferation and apoptosis in a rat mammary cancer model induced by 7, 12-dimethylbenz[a]anthracene (DMBA). Rats were fed an AIN-76A diet containing beta-ionone (0, 9, 18 or 36 mmol/kg), starting 2 weeks before DMBA administration and continuing for 24 weeks. A dose-dependent inhibition of mammary carcinogenesis by dietary beta-ionone was observed. Corresponding tumor incidence values were 82.1, 53.3, 25.9 and 10.0% (p < 0.01 or 0.05). Time to tumor appearance increased and tumor multiplicity decreased with increasing dietary beta-ionone. Histopathological and immunohistochemical evaluations of tumors were performed on the 64, 31, 15 and 3 tumors, respectively, identified in rats from the respective groups of 30. The proportions of adenocarcinomas, adenomas and benign masses were equally distributed in the latter group. In proportions within the other groups, the proportions of adenocarcinomas and benign masses decreased and increased with increasing dietary beta-ionone. Proliferating cell nuclear antigen (PCNA), cyclin D1 and Bcl-2 expression decreased, and Bax expression and nuclear fragmentation increased with increasing dietary beta-ionone. These results demonstrate the potent capacity of dietary beta-ionone to suppress DMBA-initiated mammary cancer in rats.

Beta-ionone (BI) is a degraded (C 13) sesquiterpene found in plant essential oils. It has been used in the synthesis of perfume chemicals and vitamin A. Recently, it was reported that BI is a rather potent in vitro inhibitor of CYP2B1-catalysed reactions in rat liver microsomes. The present study was performed to investigate whether inhibition of CYP2B1 reactions by BI could lead to an attenuation of cyclophosphamide (CP)-induced embryotoxicity in the rat. In a preliminary experiment, a dose-dependent prolongation of pentobarbital sleeping time in male and female Wistar rats suggested that BI inhibits CYP2B1 in vivo as well. In a second experiment, rats were treated by gavage with BI (0, 250, 500, 750 or 1000 mg/kg body wt) 45 min prior to a subcutaneous injection of either CP (7.5 mg/kg body wt) or its vehicle (saline) on day 11 of pregnancy. BI alone, at the highest dose tested, caused a high proportion of resorptions. Lower doses of BI, however, clearly attenuated CP-induced embryolethality and teratogenicity. These results seem to support the view that, as far as rats are concerned, CYP2B1 plays an important role in the conversion of CP into its embryolethal and teratogenic metabolites.

Environmental Fate · 3 件

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 670(SRC), determined from a structure estimation method(2), indicates that beta-ionone is expected to have low mobility in soil(SRC). Volatilization of beta-ionone from moist soil surfaces is expected to be an important fate process(SRC) given an estimated Henry's Law constant of 8.1X10-5 atm-cu m/mole(SRC), derived from its vapor pressure, 0.054 mm Hg(3), and water solubility, 169 mg/L(3). Even though the vapor pressure is low environmentally at standard temperature and pressure, there is a detectable odor; therefore, beta-ionone may volatilize from dry soil(SRC). A 79% of theoretical BOD using activated sludge in the OECD 301F test(5) suggests that biodegradation is an important environmental fate process in soil(SRC). beta-Ionone was also classified as readily biodegradable by the results of a CO2-evolution test where beta-ionone achieved 46% and 73% CO2 evolution after 7 and 28 days respectively(5). beta-Ionone absorbs at wavelengths >290 nm(6) and, therefore, may be susceptible to direct photolysis on soil surfaces exposed to sunlight(SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 670(SRC), determined from a structure estimation method(2), indicates that beta-ionone is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is expected(3) based upon an estimated Henry's Law constant of 8.1X10-5 atm-cu m/mole(SRC), derived from its vapor pressure, 0.054 mm Hg(4), and water solubility, 169 mg/L(4). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 19 hours and 10 days, respectively(SRC). According to a classification scheme(5), an estimated BCF of 202(SRC), from its log Kow of 4.0(6) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is high(SRC). A 79% of theoretical BOD using activated sludge in the OECD 301F test(6) suggests that biodegradation is an important environmental fate process(SRC). beta-Ionone was also classified as readily biodegradable by the results of a CO2-evolution test where beta-ionone achieved 46% and 73% CO2 evolution after 7 and 28 days respectively(6). In a spiked river water die-away test, beta-ionone, at 6.28 ug/L, was degraded about 95% after 20 hours of incubation(6). beta-Ionone is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(3). beta-Ionone is an olefin and olefins in surface waters exposed to sunlight react with photo-oxidants (such as hydroxyl radicals, peroxy radicals and singlet oxygen) with a half-life on the order of 25 days(7).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), beta-ionone, which has a vapor pressure of 0.054 mm Hg at 25 °C(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase beta-ionone is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 3.3 hours(SRC), calculated from its rate constant of 1.18X10-10 cu cm/molecule-sec at 24 deg(3). beta-Ionone is also degraded in the atmosphere by reaction with ozone and nitrate radicals. The half-life for the reaction with ozone is estimated to be 14 hours(SRC), calculated from its rate constant of 1.9X10-17 cu cm/molecule-sec at 24 °C(3). The half-life for the reaction with nitrate radicals is estimated to be 0.8 hours(SRC), calculated from its rate constant of 9.4X10-12 cu cm/molecule-sec at 24 °C(4). The nitrate radical (NO3) is the dominant atmospheric oxidant during the night-time in most atmospheric environments(5), therefore, night-time degradation appears to be a major fate process for beta-ionone(SRC). beta-Ionone absorbs at wavelengths >290 nm(6) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).

Food Survey Values · 1 件

In addition to variety of fruits, beta-ionone has detected in milk powder, beef, cognac, whiskies, grape wines, tea, rice bran, buckwheat, and corn oil(1). beta-Ionone was detected in popcorn at a concentration of 2 ug/kg(2). beta-Ionone was detected in the volatile compounds from edible Korean Chamchwi (Aster scaber Thunb)(3).

Toxicity Summary · 1 件

IDENTIFICATION AND USE: Beta-ionone (BI) is a colorless to pale, straw-colored liquid. BI is of use, not only in perfumery, but also as a key intermediate in the synthesis of Vitamins A, E, and K. HUMAN EXPOSURE AND TOXICITY: At 1% BI produced no irritation or sensitization in patients. At 5% concentration, 2 patients showed questionable positive irritation reactions, but there was no sensitization. ANIMAL STUDIES: No evidence of sensitization was observed in guinea pigs. In rabbits application of neat beta-ionone produced very slight to well-defined erythema on the abraded and intact skin at 24 hr and well defined erythema at 72 hr. Very slight conjunctival irritation was observed in all three rabbits at 0, 1, 2, and 4 hr with neat BI. In 90 day feeding study in rats BI did not produce adverse effects. In development study in BI-treated pregnant rats compared to the untreated controls, the uterus weight, the ratio of resorptions per implantations and the percentage of resorptions per implantation per litter were substantially increased, and the ratio of live fetuses per implantations per litter was drastically decreased with 1000 mg/kg; with 250, 500 and 750 mg/kg, no effects were produced. BI exhibited no mutagenic activity in Salmonella typhimurium (strains TA98, TA100, TA1535 and TA1537) at concentrations up to approximately 180 ug/plate with and without metabolic activation. ECOTOXICITY STUDIES: Ultrastructural examination by transmission electron microscopy indicated that the thylakoids were distorted, and the thylakoid membrane stacks began to collapse when M. aeruginosa NIES-843 was exposed to BI at a concentration of 22.5 and 33.75 mg/L.

Average Daily IntakeUS per capita intake of beta-ionone was 110 ug/day in 1989(1). Individual: 0.001709 mg/kg/day(2).
Ecotoxicity Excerpts · 1 件

/AQUATIC SPECIES/ In order to explore the potential targets of toxicity of beta-ionone on the photosynthetic system of Microcystis aeruginosa, the polyphasic rise in chlorophyll a (Chl a) fluorescence transient and transcript expression for key genes in photosystem II (PSII) of M. aeruginosa NIES-843 were studied. The EC50 value of beta-ionone on M. aeruginosa NIES-843 was found to be 21.23+/-1.87 mg/L. It was shown that beta-Ionone stress can lead to a decrease in pigment content of M. aeruginosa NIES-843 cells, and that carotenoids were more sensitive to beta-ionone stress than Chl a. The normalized Chl a fluorescence transients were slightly decreased at 6.67 and 10 mg/L beta-ionone, but significantly increased at 15, 22.5 and 33.75 mg/L. There was no significant variation on transcript expression of psbA and psbO at a concentration of 6.67 mg/L beta-ionone, but they were down-regulated at 22.5 mg/L. Ultrastructural examination by transmission electron microscopy indicated that the thylakoids were distorted, and the thylakoid membrane stacks began to collapse when M. aeruginosa NIES-843 was exposed to beta-ionone at a concentration of 22.5 and 33.75 mg/L. Our results indicate that the reaction center of PS II and the electron transport at the acceptor side of PS II are the targets responsible for the toxicity of beta-ionone on the PS II of M. aeruginosa NIES-843.

法規制情報

FDA Requirements · 1 件

beta-Ionone is a food additive permitted for direct addition to food for human consumption as a synthetic flavoring substance and adjuvant in accordance with the following conditions: a) they are used in the minimum quantity required to produce their intended effect, and otherwise in accordance with all the principles of good manufacturing practice, and b) they consist of one or more of the following, used alone or in combination with flavoring substances and adjuvants generally recognized as safe in food, prior-sanctioned for such use, or regulated by an appropriate section in this part.

化学と産業

薬理情報

Metabolism/Metabolites · 2 件

A 3 kg male rabbit was orally administered a total of 23 g beta-ionone for 7 days (approx. 1000 mg/kg bw/day). Urine was collected daily and for 4 days after the final dose. Allylic ring oxidation and ketone reduction yielded 3-oxo-ionone, 3-oxo-beta-ionol, dihydro-3-oxo-beta-ionol, and 3-hydroxy-beta-ionol, which were detected in the urine. Unchanged beta-ionone and the glucuronic acid conjugates of 3-oxo-beta-ionol and dihydro-3-oxo-beta-ionol were also detected.

/Researchers/ fed beta-ionone to three rabbits in daily increasing doses of 2-5 g with a total dose of about 30 g in one week. In another test, feeding continued for two weeks in daily doses of 4 g, which increased to 5 g towards the end. In this schedule, the dose was not administered on some days. Urine was collected from all animals and analyzed for the presence of metabolites. The metabolites identified included 3-oxo-beta-ionone, bionol, dihydro-beta-ionol, oxy-beta-ionol, oxy-dihydro-beta-ionol, and oxy-dihydro-beta-ionone. Tetrahydro derivatives and multiple unsaturated products formed by dehydrogenation were not seen. Two separate feeding tests conducted in the spring and in the fall showed that conversion products of beta-ionone which are hydrogenated to the -hydroxyl and -carbonyl groups were excreted in the spring but not in the fall.

用途と製造

Uses · 3 件

Fragrance ingredient in perfumery, in cosmetics and personal care products, in household cleaners and detergents. Flavoring agent in beverages, baked goods, and candies. /Ionone/

beta-Ionone is of use, not only in perfumery, but also as a key intermediate in the synthesis of Vitamins A, E, and K.

Reported uses (ppm):

U.S. Production · 2 件

2023: 7,000,000 - <8,500,000 lb

Non-confidential 2012 Chemical Data Reporting (CDR) information on the production and use of chemicals manufactured or imported into the United States. Chemical: 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-. National Production Volume: Withheld.

Consumer UsesFragrance
Industry UsesFragrance
Methods of ManufacturingBy condensing citral with acetone to form pseudoionone, which is then cyclized by acid-type reagents.
Household ProductsInformation on 88 consumer products that contain Beta-Ionone in the following categories is provided:

関連反応

1 件

関連ノート

読み込み中…